​

Senti Biosciences (SNTI) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

SNTI Stock Forecast

Senti Biosciences (SNTI) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $6.00, with a high of $6.00 and a low of $6.00. This represents a 525.00% increase from the last price of $0.96.

- $1 $2 $3 $4 $5 $6 High: $6 Avg: $6 Low: $6 Last Closed Price: $0.96

SNTI Stock Rating

Senti Biosciences stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 2 Buy (50.00%), 2 Hold (50.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 2 2 Strong Sell Sell Hold Buy Strong Buy

SNTI Price Target Upside V Benchmarks

TypeNameUpside
StockSenti Biosciences525.00%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$6.00
Last Closing Price$0.96$0.96$0.96
Upside/Downside--525.00%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 2613---4
Mar, 2613---4
Feb, 2613---4
Jan, 2613---4
Dec, 2513---4
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 21, 2025Jeffrey La RosaLeerink Partners$6.00$1.82229.67%525.00%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Nov 21, 2025Leerink PartnersOutperforminitialise
Oct 14, 2025H.C. WainwrightBuyinitialise
Jun 06, 2025LaidlawBuyinitialise

Financial Forecast

EPS Forecast

$-25 $-20 $-15 $-10 $-5 $0 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-13.25$-20.94$-11.49$-2.73-
Avg Forecast$-1.64$-17.50$-14.54$-1.88$-5.80
High Forecast$-1.64$-17.50$-14.54$-1.88$-5.80
Low Forecast$-1.64$-17.50$-14.54$-1.88$-5.80
Surprise %707.93%19.66%-20.98%45.21%-

Revenue Forecast

$0 $1M $2M $3M $4M $5M Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$3.29M$1.98M-$22.00K-
Avg Forecast$4.05M$3.46M$2.80M$5.00M$3.80M
High Forecast$4.05M$3.46M$2.80M$5.00M$3.80M
Low Forecast$4.05M$3.46M$2.80M$5.00M$3.80M
Surprise %-18.80%-42.85%--99.56%-

Net Income Forecast

$-80M $-65M $-50M $-35M $-20M $-5M Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-58.21M$-71.06M$-52.79M$-61.44M-
Avg Forecast$-7.28M$-77.65M$-64.52M$-8.34M$-25.74M
High Forecast$-7.28M$-77.65M$-64.52M$-8.34M$-25.74M
Low Forecast$-7.28M$-77.65M$-64.52M$-8.34M$-25.74M
Surprise %699.25%-8.49%-18.18%636.49%-

SNTI Forecast FAQ

Is Senti Biosciences stock a buy?

Senti Biosciences stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 2 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Senti Biosciences is a favorable investment for most analysts.

What is Senti Biosciences's price target?

Senti Biosciences's price target, set by 4 Wall Street analysts, averages $6 over the next 12 months. The price target range spans from $6 at the low end to $6 at the high end, suggesting a potential 525.00% change from the previous closing price of $0.96.

How does Senti Biosciences stock forecast compare to its benchmarks?

Senti Biosciences's stock forecast shows a 525.00% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Senti Biosciences over the past three months?

  • April 2026: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2026: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Senti Biosciences’s EPS forecast?

Senti Biosciences's average annual EPS forecast for its fiscal year ending in December 2026 is $-5.8, marking a 112.45% increase from the reported $-2.73 in 2025..

What is Senti Biosciences’s revenue forecast?

Senti Biosciences's average annual revenue forecast for its fiscal year ending in December 2026 is $3.8M, reflecting a 17172.73% increase from the reported $22K in 2025.

What is Senti Biosciences’s net income forecast?

Senti Biosciences's net income forecast for the fiscal year ending in December 2026 stands at $-25.736M, representing a -58.11% decrease from the reported $-61.438M in 2025.